Resolute Advisors’s Idexx Laboratories IDXX Stock Holding History

Resolute Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-16	Closed	-$10K	–	350
2021 Q3	$10K	Hold	16	–	–	﹤0.01%	324
2021 Q2	$10K	Buy	+16	New	+$8.84K	﹤0.01%	277
2021 Q1	–	Sell	-3	Closed	-$2K	–	438
2020 Q4	$2K	Buy	+3	New	+$1.34K	﹤0.01%	83

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Resolute Advisors's IDXX Position: Q4 2021 in Review

Resolute Advisors sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 16 shares — an estimated $10K sold.

Resolute Advisors first reported a position in IDXX in Q4 2020 and held it in 3 quarters. The position peaked at $10K in Q3 2021. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

Resolute Advisors reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
Resolute Advisors sold 16 Idexx Laboratories shares in Q4 2021, an estimated $10K.
Resolute Advisors first reported a position in Idexx Laboratories in Q4 2020 and held it in 3 quarters.
Resolute Advisors's Idexx Laboratories position peaked at $10K in Q3 2021.
1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on Resolute Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.